Aligos Therapeutics, Inc. (ALGS) vs Grace Therapeutics, Inc. (GRCE)
A side-by-side comparison of Aligos Therapeutics, Inc. and Grace Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALGS
Aligos Therapeutics, Inc.
$5.37HealthcareDelayed quote: Oct 6, 2026, 12:17 PM EDT
GRCE
Grace Therapeutics, Inc.
$2.13HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
Total return — ALGS vs GRCE
growth of $100 · dividends reinvested · last 2yALGS -37.4% (-20.9%/yr)GRCE -31.6% (-17.3%/yr)GRCE compounded faster over this window
ALGS GRCE
ALGS vs GRCE: by the numbers
- •GRCE is the larger company ($35M vs $33M market cap).
- •Both run net losses; GRCE's is the smaller (0.00% vs -241.01% net margin).
Metrics side by side
Valuation
| Metric | ALGS | GRCE |
|---|---|---|
| P/S ratio | 1.05 | N/A |
| P/B ratio | 1.04 | 0.72 |
Profitability
| Metric | ALGS | GRCE |
|---|---|---|
| Gross margin | 57.46% | 0.00% |
| Operating margin | -4024.93% | 0.00% |
| Net margin | -241.01% | 0.00% |
| ROE | -238.24% | -44.50% |
| ROIC | -207.97% | -52.61% |
Growth (annualized)
| Metric | ALGS | GRCE |
|---|---|---|
| Revenue CAGR (5Y) | -15.85% | N/A |
| Total return CAGR (5Y) | -57.15% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.